Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like congatec introduces SMARC 2.0 Quick Starter Kit for NXP i.MX 8 QuadMax processor family March 14, 2019 ITSENCLOSURES announces PB282626-0 printer enclosure February 13, 2019 AIStorm introduces semi-custom IoT Vision / IoT Waveform and ADAS Solutions February 27, 2019
congatec introduces SMARC 2.0 Quick Starter Kit for NXP i.MX 8 QuadMax processor family March 14, 2019